Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIMAS: Safety of Crushed Deferasirox in Pediatric Transfusional Hemosiderosis
NCT03372083Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of deferasirox in transfusion hemosiderosis, sponsored by Novartis. Started Jan 2018; status: completed.
02
Drugs
deferasirox
03
Conditions
transfusion hemosiderosis
Beyond the preview
Go deeper on NCT03372083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372083.